In their study, it was observed that CUR-loaded T807/RPCNP NPs can relieve AD symptoms by reducing p-tau levels and suppressing neuronal-like cell death both in vitro and in vivo [16]. This evidence concerns the gene MAPT and Alzheimer disease.